Ultragenyx Pharmaceutical, Inc.
RARE · NASDAQ · USD
$15.29
+0.40 2.69%todayNot financial advice.
- Open
- 14.79
- Day range
- 14.43 - 15.52
- 52-week range
- 12.73 - 39.89
- Volume
- 5.4M
- Market cap
- 1.51B
- P/E ratio
- —
- EPS
- -5.84
- Dividend yield
- 0.00%
- Beta
- 2.24
Performance
W
+1.73%
1M
+1.28%
3M
−55.82%
6M
−36.34%
YTD
−33.06%
Y
−48.59%
5Y
−82.10%
All
−66.62%
In the news
Oct 8
Ultragenyx to Sell FDA Priority Review Voucher for $210 Million to Boost Cash
Ultragenyx Pharmaceutical will sell its FDA priority review voucher for $210 million to secure non-dilutive funding for its rare-disease treatments.
Company news
Oct 7
Ultragenyx to Sell Priority Review Voucher for $210 Million Cash
Ultragenyx Pharmaceutical is selling its pediatric priority review voucher for $210 million in cash to boost liquidity by monetizing a non-core asset.
Company news
Oct 7
Ultragenyx to Sell FDA Priority Review Voucher for $210 Million
Ultragenyx Pharmaceutical is selling its FDA priority review voucher for $210 million to secure non-dilutive capital and fund its drug pipeline.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-RARE" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Ultragenyx Pharmaceutical, Inc. (RARE) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-RARE">RARE stock price</a> by FreeTheAI Stocks</p>